中國中期(000996.SZ)延期回覆深交所關注函
格隆匯12月23日丨中國中期(000996.SZ)公佈,公司於2019年12月17日收到深圳證券交易所《關於對中國中期投資股份有限公司的關注函》(公司部關注函[2019]第141號)(“關注函”)。關注函中要求公司於2019年12月23日前將有關説明材料報送深圳證券交易所並對外披露。
接到關注函後,公司立即組織相關人員開展對關注函的回覆工作,對涉及的問題進行落實和核查。鑑於關注函中部分事項尚需進一步核實,公司預計無法按期完成關注函的全部回覆工作。為保證信息披露的真實、準確、完整,經向深圳證券交易所申請,公司將於2019年12月25日前回復此次關注函。公司將盡快完成此次關注函的回覆工作,並及時履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.